Ff/umec/vi

Ismaila, A. S., Rothnie, K. J., Wood, R. P., Banks, V. L., Camidge, L. J., Czira, A., et al. (2023). Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study. Respir Res, 24, 229. http://doi.org/10.1186/s12931-023-02523-1